Spike Protein Persistence: A Complete Evidence Guide
Last updated: July 6, 2026
The definitive overview of how long SARS-CoV-2 spike protein and vaccine-encoded spike persist in the human body — from circulating pg/mL levels to tissue reservoirs lasting months to years.
Overview
Spike protein persistence describes continued antigen detection after SARS-CoV-2 infection or COVID-19 vaccination. Most individuals clear circulating spike within weeks, but ultra-sensitive assays (Simoa, high-sensitivity ELISA) detect low pg/mL levels in subsets for months to years. The 2026 systematic review synthesizes evidence across bodily fluids and autopsy tissues.
Blood & circulating levels
Positive samples typically fall in the low pg/mL range. Yonker et al. reported ~34 pg/mL in mRNA vaccine myocarditis cases. Swank et al. detected circulating spike in symptomatic subsets months post-vaccination. The systematic review cites blood persistence up to ~709 days in outlier cohorts — not representative of the general vaccinated population.
View measured levels & tables →Tissue persistence
Lymph node germinal centers harbor vaccine antigen for 8+ months (Röltgen et al., Cell 2022). Autopsy series (Fehrer et al.) report spike and mRNA in heart, liver, spleen, and brain-meningeal borders. Limited data suggest skull-brain interface deposits persisting up to ~4 years — requiring independent replication.
Vaccine-derived vs. infection-derived spike
Infection typically produces higher peak antigen loads; vaccine platforms (mRNA, viral vector) show heterogeneous clearance kinetics. Most assays cannot distinguish source without genomic sequencing. Both pathways may contribute to Long COVID/PASC hypotheses in overlapping symptom profiles.
Detection assays
- Simoa — ultra-sensitive; detects sub-pg/mL in research settings
- ELISA — widely used; variable LOD across commercial kits
- IHC / ISH — tissue localization in autopsy/biopsy
- RT-qPCR — vaccine mRNA detection in cells/tissues
Key studies timeline
The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review
Various · BMC Infectious Diseases
Long COVID neuropathy: The role of mast cells.
Morcos Zachary L · Journal of neuropathology and experimental neurology
SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19.
Mezache Louisa · Scientific reports
SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.
de Melo Bruno Pereira · Viruses
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination.
Fanti Silvia · Circulation
Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2.
Kumar Sahil · Nature communications
Mitochondrial Reactive Oxygen Species: A Unifying Mechanism in Long COVID and Spike Protein-Associated Injury: A Narrative Review.
Lee Eunseuk · Biomolecules
SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis.
Westman Henrik · Biochemistry
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?
Lesgards Jean-François · International journal of molecular sciences
Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants.
Li Pei · mBio
Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS.
Fehrer Annick · Journal of clinical medicine
Biomarker-Based Risk Assessment Strategy for Long COVID: Leveraging Spike Protein and Proinflammatory Mediators to Inform Broader Postinfection Sequelae.
Yang Ying-Fei · Viruses
Limitations & uncertainty
Heterogeneous cohorts, assay variability, selection bias toward symptomatic patients, and small autopsy series limit generalizability. Persistence does not equal pathogenicity. Causality between spike detection and clinical symptoms remains unproven in randomized studies.